Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101K Buy
32,231
+156
+0.5% +$488 ﹤0.01% 720
2026
Q1
$93.7K Hold
32,075
﹤0.01% 683
2025
Q4
$79.2K Hold
32,075
﹤0.01% 724
2025
Q3
$71.5K Hold
32,075
﹤0.01% 690
2025
Q2
$77.3K Hold
32,075
﹤0.01% 674
2025
Q1
$74.7K Buy
+32,075
New +$64.2K ﹤0.01% 656

Other funds holding ABEV

Cullen/Frost Bankers's ABEV Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Ambev (ABEV) stake by 0.49% in Q2 2026, buying an estimated $488 and bringing the position to 32,231 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #720.

Cullen/Frost Bankers first reported a position in ABEV in Q1 2025 and has held it in 6 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Cullen/Frost Bankers held 32,231 shares of Ambev worth $101K as of Q2 2026.
  • Cullen/Frost Bankers bought 156 Ambev shares in Q2 2026, an estimated $488.
  • Ambev made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #720 holding.
  • Cullen/Frost Bankers first reported a position in Ambev in Q1 2025 and has held it in 6 quarters since.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.